These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16442240)

  • 1. Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy.
    Underberg RW; Lagerwaard FJ; van Tinteren H; Cuijpers JP; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1221-8. PubMed ID: 16442240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer.
    Underberg RW; Lagerwaard FJ; Cuijpers JP; Slotman BJ; van Sörnsen de Koste JR; Senan S
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1283-90. PubMed ID: 15519801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is adaptive treatment planning required for stereotactic radiotherapy of stage I non-small-cell lung cancer?
    Haasbeek CJ; Lagerwaard FJ; Cuijpers JP; Slotman BJ; Senan S
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1370-4. PubMed ID: 17275206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining target volumes for stereotactic ablative radiotherapy of early-stage lung tumours: a comparison of three-dimensional 18F-fluorodeoxyglucose positron emission tomography and four-dimensional computed tomography.
    Hanna GG; van Sörnsen de Koste JR; Dahele MR; Carson KJ; Haasbeek CJ; Migchielsen R; Hounsell AR; Senan S
    Clin Oncol (R Coll Radiol); 2012 Aug; 24(6):e71-80. PubMed ID: 22445302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification and minimization of uncertainties of internal target volume for stereotactic body radiation therapy of lung cancer.
    Ge H; Cai J; Kelsey CR; Yin FF
    Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):438-43. PubMed ID: 22687196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4DCT datasets.
    Underberg RW; Lagerwaard FJ; Slotman BJ; Cuijpers JP; Senan S
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):554-60. PubMed ID: 15890600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving target delineation on 4-dimensional CT scans in stage I NSCLC using a deformable registration tool.
    van Dam IE; van Sörnsen de Koste JR; Hanna GG; Muirhead R; Slotman BJ; Senan S
    Radiother Oncol; 2010 Jul; 96(1):67-72. PubMed ID: 20570381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of target volumes generated using uncoached 4-dimensional CT scans for peripheral lung cancer.
    van der Geld YG; Lagerwaard FJ; van Sörnsen de Koste JR; Cuijpers JP; Slotman BJ; Senan S
    Radiat Oncol; 2006 Nov; 1():43. PubMed ID: 17078882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel simple approach for incorporation of respiratory motion in stereotactic treatments of lung tumors.
    Cuijpers JP; Verbakel WF; Slotman BJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):443-8. PubMed ID: 21047693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability.
    Altorjai G; Fotina I; Lütgendorf-Caucig C; Stock M; Pötter R; Georg D; Dieckmann K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e265-72. PubMed ID: 21620581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer.
    Ikushima H; Balter P; Komaki R; Hunjun S; Bucci MK; Liao Z; McAleer MF; Yu ZH; Zhang Y; Chang JY; Dong L
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):473-80. PubMed ID: 20399032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Maximum Intensity Projections (MIPs) for target outlining in 4DCT radiotherapy planning.
    Muirhead R; McNee SG; Featherstone C; Moore K; Muscat S
    J Thorac Oncol; 2008 Dec; 3(12):1433-8. PubMed ID: 19057269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect?
    Siker ML; Tomé WA; Mehta MP
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):135-41. PubMed ID: 16839704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor location cannot predict the mobility of lung tumors: a 3D analysis of data generated from multiple CT scans.
    van Sörnsen de Koste JR; Lagerwaard FJ; Nijssen-Visser MR; Graveland WJ; Senan S
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):348-54. PubMed ID: 12738308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality assurance of 4D-CT scan techniques in multicenter phase III trial of surgery versus stereotactic radiotherapy (radiosurgery or surgery for operable early stage (stage 1A) non-small-cell lung cancer [ROSEL] study).
    Hurkmans CW; van Lieshout M; Schuring D; van Heumen MJ; Cuijpers JP; Lagerwaard FJ; Widder J; van der Heide UA; Senan S
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):918-27. PubMed ID: 20950961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in position and volume of lung cancer target volumes during stereotactic body radiotherapy (SBRT): is image guidance necessary?
    Yi BS; Perks J; Houston R; Stern R; Purdy JA; Chen AM
    Technol Cancer Res Treat; 2011 Oct; 10(5):495-504. PubMed ID: 21895034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric impact of breathing motion in lung stereotactic body radiotherapy treatment using intensity modulated radiotherapy and volumetric modulated arc therapy [corrected].
    Rao M; Wu J; Cao D; Wong T; Mehta V; Shepard D; Ye J
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):e251-6. PubMed ID: 22365622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic analysis of microscopic extension in lung adenocarcinoma: defining clinical target volume for radiotherapy.
    Grills IS; Fitch DL; Goldstein NS; Yan D; Chmielewski GW; Welsh RJ; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):334-41. PubMed ID: 17570609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cine computed tomography without respiratory surrogate in planning stereotactic radiotherapy for non-small-cell lung cancer.
    Riegel AC; Chang JY; Vedam SS; Johnson V; Chi PC; Pan T
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):433-41. PubMed ID: 18644683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical implications of defining the gross tumor volume with combination of CT and 18FDG-positron emission tomography in non-small-cell lung cancer.
    Grills IS; Yan D; Black QC; Wong CY; Martinez AA; Kestin LL
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):709-19. PubMed ID: 17197120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.